Clinical Trials Directory

Trials / Completed

CompletedNCT03264573

Role of Stem Cells, Platelet Rich Plasma in Treatment of Scars

Role of Stem Cells, Platelet Rich Plasma and Combination of Them in Treatment of Scars

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Heba Mohamed Saad Eldien · Academic / Other
Sex
All
Age
10 Years – 35 Years
Healthy volunteers
Accepted

Summary

The Objectives of this randomized controlled trial aiming to establishing a protocol of post scar revision care and to Study the effect of PRP and/or Adipose derived Mesenchymal Stem cell injection in improvement of atrophic scar after scar revision.

Detailed description

Forty patients with atrophic scar since one to five years including 25 males and 15 females with ages ranging from ten to 35 years with main age of 22.68 will be divided into four groups each included ten patients. One group will be treated with scar revision only (control group or group I), 2nd group will be injected with PRP after scar revision, 3rd group will be injected with ADSCs after scar revision and the 4th group will be injected with a combination of PRP and ADSCs after scar revision. All groups were assisted pre-operative and six months post-operative. Complications, Scar width, Vancouver scar scale (VSS), surgeon assessment scar scale and patient assessment scar scale will be considered the outcome measurements.

Conditions

Interventions

TypeNameDescription
BIOLOGICALStem cellafter scar revision PRP is injected intradermally, also adipose derived mesenchymal stem cells
DEVICEMSCsmanual separation of platelets rich plasma and undifferentiated mesenchymal stem cells

Timeline

Start date
2016-07-01
Primary completion
2017-02-01
Completion
2017-07-01
First posted
2017-08-29
Last updated
2017-08-29

Source: ClinicalTrials.gov record NCT03264573. Inclusion in this directory is not an endorsement.